Akebia Therapeutics AKBA Cash Flow Statement (2013-2026)

NASDAQ AKBA
$0.89 +0.01 (+0.77%)
At close: Aug 20, 2026 · 1:57 PM UTC
Cash Flow Statement Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-57.59M-68.14M-62.28M31.38M-52.51M-4.12M-26.88M-11.17M-14.49M0.61M-17.98M-8.58M-20.04M-22.80M6.11M0.25M0.54M-12.24M-9.05M-8.91M
Depreciation and Depletion (Quarter)
0.41M0.40M0.40M0.40M0.39M0.36M0.40M0.36M0.34M0.31M0.32M0.32M0.32M0.33M0.58M
Share-based Compensation (Quarter)
5.59M4.64M4.54M6.92M3.35M3.04M2.49M3.49M1.82M1.51M2.36M2.07M1.65M1.70M2.19M2.68M3.22M3.20M3.67M3.23M
Gains from Investment Securities (Quarter)
0.13M-2.33M0.86M1.68M-0.15M6.98M-1.46M-2.26M-0.46M-0.57M
Asset Writedowns and Impairment (Quarter)
1.70M-7.13M5.30M2.10M2.60M-9.59M0.34M0.30M0.70M-1.33M0.59M0.50M1.30M-2.11M0.16M0.50M-0.65M3.22M1.70M
Cash from Operations (Quarter)
-56.27M-62.81M-21.62M-30.66M33.80M-54.68M-17.54M3.63M-7.17M-2.31M-19.43M-10.07M-6.70M-4.47M-13.59M22.34M28.11M31.13M-21.21M3.52M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
Amortization of Deferred Charges (Quarter)
0.31M0.31M0.25M0.67M0.55M0.65M0.50M0.48M0.34M-3.55M0.33M-0.10M7.25M5.59M6.25M6.18M4.62M4.75M4.58M2.81M
Depreciation & Amortization (CF) (Quarter)
0.47M0.44M0.42M0.42M0.41M0.41M0.40M0.40M0.40M0.39M0.36M0.40M0.36M0.34M0.31M0.32M0.32M0.32M0.33M0.58M
Change in Working Capital
Change in Receivables (Quarter)
14.69M1.19M13.78M16.64M-58.73M17.02M-21.55M0.84M3.02M16.70M-12.67M3.15M2.40M3.07M27.87M11.53M-6.16M-19.10M15.70M-9.03M
Change in Inventory (Quarter)
-0.43M-10.34M8.49M-4.13M1.00M-24.45M-7.35M-3.48M1.59M11.78M4.43M14.93M0.55M8.50M4.95M7.65M-6.90M17.42M2.54M0.66M
Change in Account Payables (Quarter)
-13.81M3.20M-7.36M-1.45M-8.61M18.92M-9.01M-3.04M2.31M4.50M-7.50M6.78M-3.03M2.39M-2.23M3.73M-8.83M10.42M-7.79M2.60M
Change in Accured Expenses (Quarter)
30.80M-37.18M7.39M-26.85M-2.07M-16.47M-25.11M5.73M5.65M3.71M-15.04M0.52M-3.13M4.88M2.77M16.01M15.82M13.93M2.04M-5.44M
Other Working Capital Changes (Quarter)
28.32M-6.36M-9.02M8.46M-9.24M8.74M-7.38M-0.31M-2.36M-1.80M-1.41M0.13M-5.52M-2.09M-2.21M-1.31M-2.50M-1.56M-0.17M2.17M
Investing Activities
Capital Expenditures (Quarter)
4.21M-3.97M-6.05M10.13M2.81M-2.81M8.18M-8.18M0.61M-1.06M0.48M-0.65M0.02M0.13M0.08M2.40M0.75M0.39M
Sales of Property, Plant and Equipment (Quarter)
0.17M
Change in Acquisitions & Divestments (Quarter)
Cash from Investing Activities (Quarter)
-0.11M-0.03M-0.00M-0.00M0.15M-0.13M-0.08M-7.88M-0.06M-4.08M
Financing Activities
Other financing activities (Quarter)
-44.04M0.37M-0.30M0.34M0.03M-0.03M0.00M0.14M0.01M-0.00M0.00M0.48M-0.40M0.15M0.02M
Cash from Financing Activities (Quarter)
16.48M5.40M47.55M-0.01M-32.94M-0.00M-15.97M-8.00M0.05M-1.29M18.48M7.64M1.22M22.32M74.94M1.72M1.11M-4.85M-0.93M-6.54M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
Additional items
Change in Cash (Quarter)
-39.79M-57.41M25.81M-30.67M0.87M-54.68M-33.50M-4.37M-7.12M-3.60M-0.96M-2.46M-5.47M17.86M61.51M23.94M29.14M18.40M-22.20M-7.09M
Free Cash Flow (Quarter)
-60.48M-62.81M-17.65M-24.61M23.68M-54.68M-20.35M6.44M-15.34M5.87M-20.05M-9.00M-7.18M-3.81M-13.61M22.22M28.03M28.73M-21.96M3.13M
Net Cash Flow (Quarter)
-39.79M-57.41M25.81M-30.67M0.87M-54.68M-33.50M-4.37M-7.12M-3.60M-0.96M-2.46M-5.47M17.86M61.51M23.94M29.14M18.40M-22.20M-7.09M